Baggio LL - Search Results

1

Treatment of type 2 diabetes with the designer cytokine IC7Fc.

Findeisen M, Allen TL, Henstridge DC, Kammoun H, Brandon AE, Baggio LL, Watt KI, Pal M, Cron L, Estevez E, Yang C, Kowalski GM, O'Reilly L, Egan C, Sun E, Thai LM, Krippner G, Adams TE, Lee RS, Grötzinger J, Garbers C, Risis S, Kraakman MJ, Mellet NA, Sligar J, Kimber ET, Young RL, Cowley MA, Bruce CR, Meikle PJ, Baldock PA, Gregorevic P, Biden TJ, Cooney GJ, Keating DJ, Drucker DJ, Rose-John S, Febbraio MA. Findeisen M, et al. Among authors: baggio ll. Nature. 2019 Oct;574(7776):63-68. doi: 10.1038/s41586-019-1601-9. Epub 2019 Sep 25. Nature. 2019. PMID: 31554967

2

Sustained expression of exendin-4 does not perturb glucose homeostasis, beta-cell mass, or food intake in metallothionein-preproexendin transgenic mice.

Baggio L, Adatia F, Bock T, Brubaker PL, Drucker DJ. Baggio L, et al. J Biol Chem. 2000 Nov 3;275(44):34471-7. doi: 10.1074/jbc.M005119200. J Biol Chem. 2000. PMID: 10952981 Free article.

3

Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, regulates fasting glycemia and nonenteral glucose clearance in mice.

Baggio L, Kieffer TJ, Drucker DJ. Baggio L, et al. Endocrinology. 2000 Oct;141(10):3703-9. doi: 10.1210/endo.141.10.7720. Endocrinology. 2000. PMID: 11014225

4

New developments in the biology of the glucagon-like peptides GLP-1 and GLP-2.

Drucker DJ, Lovshin J, Baggio L, Nian M, Adatia F, Boushey RP, Liu Y, Saleh J, Yusta B, Scrocchi L. Drucker DJ, et al. Ann N Y Acad Sci. 2000;921:226-32. doi: 10.1111/j.1749-6632.2000.tb06970.x. Ann N Y Acad Sci. 2000. PMID: 11193827 Review.

5

Cellular specificity of proexendin-4 processing in mammalian cells in vitro and in vivo.

Adatia FA, Baggio LL, Xiao Q, Drucker DJ, Brubaker PL. Adatia FA, et al. Among authors: baggio ll. Endocrinology. 2002 Sep;143(9):3464-71. doi: 10.1210/en.2002-220251. Endocrinology. 2002. PMID: 12193559

6

Development and characterization of a glucagon-like peptide 1-albumin conjugate: the ability to activate the glucagon-like peptide 1 receptor in vivo.

Kim JG, Baggio LL, Bridon DP, Castaigne JP, Robitaille MF, Jetté L, Benquet C, Drucker DJ. Kim JG, et al. Among authors: baggio ll. Diabetes. 2003 Mar;52(3):751-9. doi: 10.2337/diabetes.52.3.751. Diabetes. 2003. PMID: 12606517

7

Hypoglycemia, defective islet glucagon secretion, but normal islet mass in mice with a disruption of the gastrin gene.

Boushey RP, Abadir A, Flamez D, Baggio LL, Li Y, Berger V, Marshall BA, Finegood D, Wang TC, Schuit F, Drucker DJ. Boushey RP, et al. Among authors: baggio ll. Gastroenterology. 2003 Oct;125(4):1164-74. doi: 10.1016/s0016-5085(03)01195-8. Gastroenterology. 2003. PMID: 14517799

8

Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.

Baggio LL, Huang Q, Brown TJ, Drucker DJ. Baggio LL, et al. Gastroenterology. 2004 Aug;127(2):546-58. doi: 10.1053/j.gastro.2004.04.063. Gastroenterology. 2004. PMID: 15300587

9

A recombinant human glucagon-like peptide (GLP)-1-albumin protein (albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis.

Baggio LL, Huang Q, Brown TJ, Drucker DJ. Baggio LL, et al. Diabetes. 2004 Sep;53(9):2492-500. doi: 10.2337/diabetes.53.9.2492. Diabetes. 2004. PMID: 15331566

10

Clinical endocrinology and metabolism. Glucagon-like peptide-1 and glucagon-like peptide-2.

Baggio LL, Drucker DJ. Baggio LL, et al. Best Pract Res Clin Endocrinol Metab. 2004 Dec;18(4):531-54. doi: 10.1016/j.beem.2004.08.001. Best Pract Res Clin Endocrinol Metab. 2004. PMID: 15533774 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

66 results

Search Page